HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

VB4-845

a phase I clinical study of intratumorally administered VB4-845, an anti-epithelial cell adhesion molecule recombinant fusion protein, in patients with squamous cell carcinoma of the head and neck
Networked: 7 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Cizeau, Jeannick: 4 articles (07/2011 - 01/2009)
2. MacDonald, Glen C: 4 articles (07/2011 - 01/2009)
3. Entwistle, Joycelyn: 4 articles (07/2011 - 01/2009)
4. Kowalski, Mark: 2 articles (01/2010 - 01/2009)
5. Spearman, Maureen: 2 articles (08/2009 - 01/2009)
6. Bosc, Denis: 2 articles (08/2009 - 01/2009)
7. Ban, Daisuke: 1 article (04/2014)
8. Tanabe, Minoru: 1 article (04/2014)
9. Nakamura, Noriaki: 1 article (04/2014)
10. Murakata, Ayano: 1 article (04/2014)

Related Diseases

1. Urinary Bladder Neoplasms (Bladder Cancer)
2. Squamous Cell Carcinoma (Epidermoid Carcinoma)
3. Transitional Cell Carcinoma
4. Neoplasms (Cancer)
5. Head and Neck Neoplasms (Head and Neck Cancer)

Related Drugs and Biologics

1. Immunotoxins (Immunotoxin)
2. Fluorouracil (Carac)
3. Exotoxins

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)